Unitech Internat (531867)
TurnaroundScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹5.67 |
| Market Cap | ₹5.95 Cr |
| P/E Ratio | 0 |
| ROCE | -536.59% |
| ROE | 8.01% |
| Dividend Yield | 0% |
| Profit Growth | 0% |
| Debt/Equity | — |
| Sales Growth | 0% |
| 52-Week Range | ₹2.89 — ₹5.67 |
| Sector | Chemicals & Petrochemicals |
Strengths
- ROE of 8.01% is positive, suggesting some equity isn't completely loss-making.
- Piotroski F-Score of 6/9 is a moderate, not deeply distressed, financial health score.
- Latest quarter net loss is negligible at -₹0 crore, not a large cash burn.
- Current price is at the top of the 52-week range, indicating market interest.
Concerns
- Latest quarter sales are ₹0 crore, meaning the business is not currently generating revenue.
- ROCE of -536.59% shows severe capital inefficiency and value destruction.
- P/E, P/B, book value, debt/equity, and promoter holding are unavailable, making risk assessment impossible.
- Zero dividend, zero growth, and no meaningful earnings provide no fundamental support for the current price.
AI Analysis
At ₹5.67, Unitech Internat carries a market cap of just ₹6 crore. The first lesson Ben Graham taught me is that you cannot value what you cannot measure. Here, P/E is 0.00, book value is unavailable, promoter holding is unavailable, and the FairStock Score is insufficient data. The latest quarter shows sales of ₹0 crore and a net profit of -₹0 crore. That is no real revenue engine. ROCE of -536.59% tells me this company is destroying value on the capital it employs, not earning a return. ROE of 8.01% sounds positive, but with no meaningful sales and a negligible profit, I cannot treat it as evidence of a durable competitive advantage. The Piotroski F-Score of 6/9 is moderate, but a checklist score cannot replace a real understanding of the business. The shares are at the top of a 52-week range of ₹2.89 to ₹5.67, yet there is no earnings growth and no dividend. That looks like speculation, not investment. This is not a predictable slow grower or a measurable asset play. At best, it is a possible turnaround, but I have no evidence that the turn has started. I would wait until the company generates sales, fixes its capital efficiency, and discloses its balance sheet and ownership structure. Until then, I cannot determine intrinsic value. Graham said price is what you pay, value is what you get; here, I cannot get a handle on value.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer